✦ LIBER ✦

The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases

✍ Scribed by Dearg S. Brown; John G. Cumming; Paul Bethel; Jonathan Finlayson; Stefan Gerhardt; Ian Nash; Richard A. Pauptit; Kurt G. Pike; Alan Reid; Wendy Snelson; Steve Swallow; Caroline Thompson

Book ID: 113496915
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 864 KB
Volume: 22
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2012.04.116

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: The Discovery of N-

ChemInform Abstract: The Discovery of N-Cyclopropyl-4-methyl-3- [6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703, a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases.

✍ John G. Cumming; et al. et al. 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 45 KB

Novel Inhibitor of p38 MAP Kinase as an

Novel Inhibitor of p38 MAP Kinase as an Anti-TNF-α Drug: Discovery of N -[4-[2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a Potent and Orally Active Anti-Rheumatoid Arthritis Agent

✍ Miwatashi, Seiji; Arikawa, Yasuyoshi; Kotani, Etsuo; Miyamoto, Maki; Naruo, Ken- 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 382 KB

Discovery of a Novel Class of Phosphodie

Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1 H -pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia † † Coordinates of the PDE10A crystal structures have been deposited in the Protein Data Bank for compound 1 (3HQW), 2 (3HQY), 3 (3HQW) and 9 (3HR1).

✍ Verhoest, Patrick R.; Chapin, Douglas S.; Corman, Michael; Fonseca, Kari; Harms, 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 1015 KB

Correction to Discovery of a Novel Class

Correction to Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1 H -[1,2,3]triazolo[4,5- b ]pyrazin-6-yl)-1 H -pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer

✍ Cui, J. Jean; McTigue, Michele; Nambu, Mitchell; Tran-Dubé, Michelle; Pairish, M 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 124 KB

Discovery and Structure−Activity Relatio

Discovery and Structure−Activity Relationship of 3-Methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): A Highly Selective 5-Hydroxytryptamine2A Receptor Inverse Agonist for the Treatment of Arterial Thrombosis

✍ Xiong, Yifeng; Teegarden, Bradley R.; Choi, Jin-Sun Karoline; Strah-Pleynet, Son 📂 Article 📅 2010 🏛 American Chemical Society 🌐 English ⚖ 887 KB

(2 S ,3 S )-3-Amino-4-(3,3-difluoropyrro

(2 S ,3 S )-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)- N,N -dimethyl-4-oxo-2-(4-[1,2,4]triazolo[1,5- a ]- pyridin-6-ylphenyl)butanamide: A Selective α-Amino Amide Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

✍ Edmondson, Scott D.; Mastracchio, Anthony; Mathvink, Robert J.; He, Jiafang; Har 📂 Article 📅 2006 🏛 American Chemical Society 🌐 English ⚖ 355 KB